Optimizing Therapy for Patients Radioactive Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC) : Episode 10
SELECT Trial & DECISION Trial Outcomes and Lessons Learned
Francis Worden, MD, analyzes the outcomes of the SELECT and DECISION Trials, focusing on progression-free survival, and provides recommendations for their application in clinical practice.
EP: 1.Differentiated Thyroid Cancer: Examining Key Epidemiological Trends
EP: 2.Exploring Incidence and Histology of Differentiated Thyroid Cancer
EP: 3.Determining Prognosis for Patients with Differentiated Thyroid Cancer
EP: 4.Predisposition for Patients Developing DTC: Age and Gender
EP: 5.The Role of Molecular Diagnostics in Real-World DTC Management
EP: 6.Employing Liquid Biopsies and ctDNA in DTC Diagnostic Strategies
EP: 7.The Importance of Thyroidectomy in DTC Patient Care
EP: 8.Post-Thyroidectomy Management: Thyroid Hormone Replacement and TSH Suppression
EP: 9.Identifying RAI-Refractory Disease: A Key Aspect of DTC Management
Now Viewing
EP: 10.SELECT Trial & DECISION Trial Outcomes and Lessons Learned
EP: 11.Determining Which DTC Patients May Benefit from Systemic Therapy
EP: 12.Exploring Real-World Evidence Presented at ATA 2023
Related Videos
